Brussels, Belgium – In a landmark move for the advancement of phage technology, three pioneering companies—Proteon Pharmaceuticals, JAFRAL, and PTC Phage Technology Center—have officially established PhageEU ASBL, a non-profit organization headquartered in Brussels. This initiative took place during a period when many other countries, such as the United Kingdom, have undertaken independent initiatives involving policymakers.
A Unified Voice for Phage Technology
PhageEU ASBL is poised to play a pivotal role in representing the interests of the phage community across Europe. With its strategic location in the heart of the European Union, the organization is well-positioned to advocate for the adoption and integration of phage technology. The establishment of PhageEU comes at a critical juncture, as newly elected Members of the European Parliament and a new College of Commissioners prepare to take office. According to the communication from the Secretary-General of PhageEU, this transition represents a singular opportunity for the organization to shape the EU’s political and regulatory framework, thereby maximizing the potential of phages for the benefit of European citizens, patients, and farmers.
The Founding Companies: Leaders in Phage Innovation
- Proteon Pharmaceuticals: Renowned for its innovative approach to using bacteriophages in aquaculture and livestock, Proteon Pharmaceuticals is at the forefront of developing natural and effective solutions for combating bacterial infections in fish farming. Their contributions to sustainable aquaculture practices have earned them recognition and respect within the industry.
- JAFRAL: Specializing in researching and manufacturing bacteriophages, JAFRAL is committed to addressing the growing issue of antibiotic resistance. Their work focuses on harnessing the power of bacteriophages to develop alternative treatments that are both safe and effective for humans and animals.
- PTC Phage Technology Center: A leader in the research and development of phage applications, PTC Phage Technology Center is dedicated to advancing phage therapy and biocontrol solutions. Their extensive research and innovative products have positioned them as key players in the phage technology sector.
Other members listed on their organisation page are Prof David Gally from the University of Edinburgh and FinkTec a hygiene management company.
An Open Invitation to the Global Phage Community
PhageEU ASBL is now ready to welcome new members from Europe and beyond. Membership is open to a diverse range of stakeholders, including companies, national and international associations, think tanks, scientific and academic institutions, researchers, and individuals active in the field of phage technology. By bringing together a wide array of expertise and perspectives, PhageEU aims to foster a collaborative environment that accelerates the development and adoption of phage-based solutions.
Get Involved with PhageEU
Those interested in becoming a member of PhageEU and learning more about the organization are encouraged to reach out for further information. This is an exciting opportunity to be part of a groundbreaking movement that promises to revolutionize the way we approach bacterial infections and antibiotic resistance.
For more details, please refer to the attached press release, which includes messages from our Board of Directors.
For more information, please contact Margareta Przybyla, Secretary-General, at [email protected] or by phone at 0032 476 591 091.
